Each vial contains 10 mg of Melanotan-1 (afamelanotide), in lyophilized form.
Melanotan-1 (MT-1) is a synthetic linear analogue of alpha-melanocyte-stimulating hormone (alpha-MSH), a 13-amino-acid endogenous peptide. Substitutions in the native sequence increase receptor affinity and resistance to proteolysis relative to alpha-MSH.
Melanotan-1 is characterised in the literature as an agonist at the melanocortin-1 receptor (MC1R). Published in vitro work examines receptor binding affinity, cyclic AMP signalling, tyrosinase activity and eumelanin synthesis in cultured melanocytes, as well as comparative receptor selectivity against other melanocortin receptor subtypes.
Areas of published research
- Receptor binding affinity and cyclic AMP response at MC1R in cell assays
- Tyrosinase activity and eumelanin synthesis in cultured melanocytes
- Comparative selectivity against MC3R, MC4R and MC5R
- Photoprotection endpoints in dermal research literature
For research use only. Not for human or veterinary use. Not a drug, food, or cosmetic.


Reviews
There are no reviews yet.